Scarica l'app Stockscreener
4.25
3.55%
-0.1566
Dopo l'orario di chiusura:
4.25
Precedente Chiudi:
$4.4066
Aprire:
$4.2
Volume 24 ore:
6,363
Relative Volume:
1.61
Capitalizzazione di mercato:
$159.00M
Reddito:
$786.00K
Utile/perdita netta:
$-73.94M
Rapporto P/E:
-2.142
EPS:
-1.9841
Flusso di cassa netto:
$-60.81M
1 W Prestazione:
-0.70%
1M Prestazione:
+10.39%
6M Prestazione:
+5.56%
1 anno Prestazione:
+4.17%
Intervallo 1D:
$4.20
$4.25
Intervallo di 1 settimana:
$4.20
$4.52
Portata 52W:
$3.4101
$5.36
Molecular Partners Ag Adr Stock (MOLN) Company Profile
Nome
Molecular Partners Ag Adr
Settore
Industria
Telefono
-
Indirizzo
-
Compare MOLN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MOLN
Molecular Partners Ag Adr
|
4.25 | 164.86M | 786.00K | -73.94M | -60.81M | -1.9841 |
VRTX
Vertex Pharmaceuticals Inc
|
424.36 | 109.34B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
702.27 | 74.35B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
794.70 | 50.44B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
301.11 | 39.78B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
297.49 | 33.02B | 5.36B | 287.73M | 924.18M | 2.5229 |
Molecular Partners Ag Adr Stock (MOLN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-27 | Iniziato | H.C. Wainwright | Buy |
| 2022-08-30 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-08-29 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-05-25 | Aggiornamento | Credit Suisse | Underperform → Neutral |
| 2022-04-27 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2021-07-13 | Iniziato | Cowen | Outperform |
| 2021-07-12 | Ripresa | SVB Leerink | Outperform |
Mostra tutto
Molecular Partners Ag Adr Borsa (MOLN) Ultime notizie
Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences - GlobeNewswire Inc.
Molecular Partners reports phase 1 data for cancer drug MP0317 By Investing.com - Investing.com Australia
Molecular Partners reports phase 1 data for cancer drug MP0317 - Investing.com
Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Short Interest Down 20.4% in April - MarketBeat
Molecular Partners (NASDAQ:MOLN) Given "Buy" Rating at HC Wainwright - MarketBeat
H.C. Wainwright reiterates Molecular Partners stock rating at buy - Investing.com
H.C. Wainwright reiterates Molecular Partners stock rating at buy By Investing.com - Investing.com South Africa
Molecular Partners (NASDAQ:MOLN) Stock Price Up 5%Still a Buy? - MarketBeat
Short Interest in Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Drops By 18.9% - MarketBeat
HC Wainwright Brokers Increase Earnings Estimates for MOLN - Defense World
Damora Therapeutics, Inc. Common Stock (DMRA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
TD Cowen reiterates Molecular Partners stock rating on radioligand platform potential By Investing.com - Investing.com South Africa
TD Cowen reiterates Molecular Partners stock rating on radioligand platform potential - Investing.com
Molecular Partners' (MOLN) Buy Rating Reiterated at HC Wainwright - MarketBeat
Molecular Partners (NASDAQ:MOLN) Posts Quarterly Earnings Results, Misses Estimates By $0.03 EPS - MarketBeat
Molecular Partners (NASDAQ: MOLN) outlines DARPin pipeline and cash into 2028 - Stock Titan
Will Petrobras Pull Off Q4 Earnings Beat on Strong Production? - TradingView
Molecular Partners (MOLN) to Release Quarterly Earnings on Thursday - Defense World
Molecular Partners (NASDAQ:MOLN) Stock Price Down 1.5%Should You Sell? - MarketBeat
Molecular Partners Highlights Favorable MP0712 DLL3 Radiotherapeutic Imaging, U.S. Phase I/II Ready - Yahoo Finance
Research Analysts Offer Predictions for MOLN FY2025 Earnings - Defense World
Brokers Offer Predictions for MOLN FY2025 Earnings - MarketBeat
What is HC Wainwright's Estimate for MOLN Q1 Earnings? - MarketBeat
Molecular Partners stock initiated with Buy rating at H.C. Wainwright By Investing.com - Investing.com India
Molecular Partners stock initiated with Buy rating at H.C. Wainwright - Investing.com
Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Short Interest Down 17.9% in December - MarketBeat
Analysts Offer Insights on Healthcare Companies: Sanofi (OtherSNYNF) and Abivax SA Sponsored ADR (ABVX) - The Globe and Mail
Molecular Partners AG Sponsored ADR (NASDAQ:MOLN) Short Interest Update - MarketBeat
Molecular Partners (NASDAQ:MOLN) Trading Up 3.1% – Here’s What Happened - Defense World
Molecular Partners (NASDAQ:MOLN) Trading Up 3.1%Here's What Happened - MarketBeat
Molecular Partners (NASDAQ:MOLN) Price Target Cut to $3.75 by Analysts at JPMorgan Chase & Co. - Defense World
Molecular Partners (NASDAQ:MOLN) Trading Down 2.2%What's Next? - MarketBeat
EBITDA per share of Molecular Partners AG Sponsored ADR – TRADEGATE:6ML0 - TradingView
Liminatus Pharma (LIMN) Short Interest Ratio and Volume 2025 - MarketBeat
Why Serina Therapeutics Shares Are Trading Higher By Over 25%; Here Are 20 Stocks Moving Premarket - Benzinga
Molecular Partners to cut workforce by a quarter - Reuters
Citius Oncology (CTOR) Short Interest & Short Float | Updated Apr 2026 $CTOR - MarketBeat
Walmart, Deere, Applied Materials set to report earnings Thursday - Investing.com Nigeria
Here's Why Molecular Partners AG Sponsored ADR (MOLN) Could be Great Choice for a Bottom Fisher - Yahoo Finance
Molecular Partners (MOLN) Stock Forecast and Price Target 2026 - MarketBeat
Molecular Partners Announces All Board Proposals Approved at the Annual General Meeting By Investing.com - Investing.com South Africa
Skye Bioscience (SKYE) Short Interest & Short Float | Updated Nov 2025 - MarketBeat
symbol__ Stock Quote Price and Forecast - CNN
MIRA Pharmaceuticals (MIRA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Stock Market News Today - Stock Titan
Stock Ratings and Recommendations: Understanding Analyst Ratings - MarketBeat
MAIA Biotechnology (MAIA) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
Acrivon Therapeutics (ACRV) Short Interest & Short Float | Updated Mar 2026 - MarketBeat
What is the current Price Target and Forecast for Molecular Partners AG Sponsored ADR (MOLN) - Zacks Investment Research
Senti Biosciences (SNTI) Short Interest & Short Float | Updated Dec 2025 - MarketBeat
US stock market gainers for the last week of April 2022 - Nairametrics
Molecular Partners Ag Adr Azioni (MOLN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.14%
0.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):